Abstract
AbstractWith the development of lipidomics, the significance of lipid metabolism in various lung diseases has been noticed recently. Among them, cholesterol metabolism plays a crucial role in the pathological process of chronic obstructive pulmonary diseases (COPD). Cholesterol accumulation could lead to mitochondrial dysfunction, such as impaired respiration, imbalanced dynamics and decreased adenosine triphosphate production, while mitochondrial dysfunction, especially altered mitochondrial dynamics, could also disrupt lipid homeostasis in cells. This review focuses on cholesterol metabolism and mitochondrial function in COPD and discusses the potential mechanisms of the steroidogenic acute regulatory‐related lipid transfer domain family (STARD), especially STARD3. The review provides new insights for understanding the pathological process between STARD and mitochondria and new therapeutic targets in COPD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
